Independent Health Clinical Trials Coverage Update

Coverage Criteria for Clinical Trials

inv-01: Approved Clinical Trial Coverage Criteria

Covered when ALL of the following are met for Approved Clinical Trials (Commercial & Self-Funded / Medicare rules summarized):

Trial scope: Trial is conducted for prevention, detection, or treatment of cancer or another life‑threatening disease OR for detection/treatment of specified non‑life‑threatening conditions (cardiovascular disease, surgical musculoskeletal disorders of the spine, hip, and knees) or other trials allowed by the plan.

Trial authorization/funding: Trial is federally funded/approved (NIH, CDC, AHRQ, CMS, DOD, VA, or qualifying cooperative groups) OR conducted under an FDA investigational new drug (IND) application OR is an IND‑exempt drug trial.

Scientific and ethical approval: Trial has a written protocol describing a scientifically sound study that is approved by all relevant institutional review boards (IRBs) before participants are enrolled; Independent Health may request documentation.

inv-02: Routine Costs — Medicare/MA

Covered routine costs include (Medicare Advantage context):

Routine costs: Items or services that are typically provided absent a clinical trial; items or services required solely for provision/administration of the investigational item or for clinically appropriate monitoring of its effects or prevention of complications; and items or services needed for diagnosis or treatment of complications arising from the investigational item or service.

Medicare Advantage coverage follows Medicare NCD/LCD criteria and desirable trial characteristics (therapeutic intent, scientific support, appropriate design, etc.).

inv-03: Routine Costs — Covered Criteria

Covered when ALL of the following are met:

Routine patient costs coverage: Items and services that would be provided if there were no clinical trial (conventional care), clinical monitoring of investigational items, items required to administer the investigational item, prevention of complications, and other reasonable and necessary items arising from the trial are considered routine patient costs and may be covered.

Applies to Commercial, Self‑Funded, Medicare Advantage and State Products as specified.

Qualified individual: Member is covered under the plan and eligible to participate in the approved clinical trial per the trial protocol, and either was referred by an in‑network health care professional who concluded participation is appropriate or provided the plan with medical/scientific information establishing eligibility.

inv-04: Exclusions / Not Covered

Not covered (explicit exclusions):

Excluded items: The investigational item or service itself (unless it is covered outside the clinical trial); items and services provided solely to satisfy data collection and analysis needs that are not used in the direct clinical management of the patient; items and services customarily provided free‑of‑charge by the research sponsor; costs of investigational drugs or devices; costs of non‑health services required for the member to receive treatment; and costs of managing the research.

Essential Plan specifically excludes investigational drug/device costs and research management costs.

Items and services that are available free from the clinical trial sponsor are not covered. Additionally, services provided solely to satisfy data collection and analysis that are not used in the direct clinical management of the patient will be excluded. Any service that would not be covered if the member were not enrolled in a clinical trial, or that is specifically excluded by the member’s benefits, is likewise not covered. Transportation, lodging, and meals associated with participation in a clinical trial are also excluded.

Costs directly associated with investigational products and the conduct of research are excluded. This includes the costs of investigational drugs or devices, costs to manage the research, and non-health services required for the member to receive treatment. Also excluded are items and services customarily provided free-of-charge by the research sponsor and other costs that would not be covered for comparable non-investigational treatments provided during the clinical trial.

Services that are clearly inconsistent with widely accepted, established standards of care—or procedures not known to be safe or efficacious—are considered not medically necessary and are not covered. Experimental or investigational services and devices that have not been evaluated by recognized authorities or government agencies are excluded from coverage, regardless of place of service. Trials meeting Phase I–III investigational definitions are treated as investigational for coverage purposes.

The investigational item or service that is the focus of a clinical trial is not considered a routine patient cost and is not covered unless that item or service would otherwise be covered outside the context of the clinical trial. Essential Plan members specifically have no coverage for the costs of investigational drugs or devices, research management costs, or non-health services required for participation.

Coding, Identifiers, and Modifiers

Designating clinical trial servicesModifier

modifier Q0

Identify patients whose data is submitted to a data collection system (as noted for CMS Qualifying Data Collection System registry)

Clinical trial diagnosis codes, identifiers, and modifiersmixed

Z00.6	Encounter for examination for participant or control in clinical research program
V70.7	Encounter for examination for normal comparison and control in clinical research program
NCT########	8-digit National Clinical Trial (NCT) identifier required on claims (format varies by form)
Q0	Modifier Q0 appended to investigational clinical service (Category B IDE code) to indicate investigational item is the focus of the study
Q1	Modifier Q1 for routine clinical services performed within the scope of a clinical trial

Provider Responsibilities and Billing Actions

Note

Provider participation and authorization — Independent Health may require participation through a participating provider and recommends Medicare Advantage enrollees notify resource coordination

Independent Health may require that a Qualified Individual participate in an Approved Clinical Trial through a participating provider when the provider will accept the individual into the trial. If no in‑network provider has the necessary expertise to administer the Approved Clinical Trial, coverage for out‑of‑network or non‑participating providers may be approved. However, for services that can reasonably be provided within the network by qualified participating providers (for example, laboratory, diagnostic, physician or practitioner services), the member must use participating providers unless their plan includes out‑of‑network benefits. Members with out‑of‑network benefits who participate in a trial conducted outside their state or service area may incur higher member liability per their plan terms.

Providers must use appropriate codes and modifiers to designate services as part of a clinical trial (see reimbursement/Modifier Q1 guidance).
A Qualified Individual with Medicare Advantage is not required to obtain authorization to join a qualifying clinical trial, but Independent Health recommends the enrollee notify Resource Coordination to document services rendered.
Independent Health may require participation through a participating provider when available and qualified; failure to use network providers when required may affect coverage and member liability.

Background and Scope

Independent Health covers routine patient costs for members participating in approved clinical trials when the trial and participant meet policy criteria. Covered trials include those conducted for the prevention, detection, or treatment of cancer and other life‑threatening diseases, and certain non‑life‑threatening conditions identified by the plan (for example specified cardiovascular and surgical musculoskeletal disorders). Coverage also extends to federally funded trials, trials conducted under an FDA investigational drug application, and certain IND‑exempt drug trials, provided the study has a written protocol and appropriate scientific and ethical approvals.

Definitions

inv-20: Routine Patient Costs / Qualified Clinical Trial

DefinitionRoutine costs are items or services that are typically provided absent a clinical trial; items/services required solely for provision or clinically appropriate monitoring of the investigational item or service; and items/services needed for diagnosis or treatment of complications arising from the investigational item or service.

ExamplesConventional care such as hospital services, room and board, physician services, office visits, laboratory and diagnostic tests.

Monitoring and administrationClinical monitoring of the effects of the investigational item and items/services required to administer the investigational item (e.g., administration of a chemotherapy agent).

ComplicationsItems and services for the prevention of complications and other reasonable and necessary items/services arising from the trial, including diagnosis or treatment of complications.

Medicare nuanceFor Medicare Advantage enrollees, routine costs exclude the investigational item itself unless covered outside the trial; Medicare may cover routine costs but not the noncovered item itself (see Medicare rules).